Indeed, in recent decades, different drugs derived from preclinical studies have been tested to counteract painful DN—including sodium channel blockers [138,139], TRPA1 antagonists [140], and antioxidants [141] —with quite variable and/or unsatisfactory results. This evidence concerns the gene TRPA1 and liver dysplastic nodule.